Characterization of a HER-2 targeted silica-gold nanoshells for breast cancer radio-photothermal therapy

Key Points

• Targeting HER-2 enables enhanced treatment of breast cancer with silica-gold nanoshells, showing promise in therapy.
• The characterization process reported efficiency in targeting and destruction of cancer cells using radio-photothermal therapy.
• Assessment used various techniques to confirm the effectiveness and safety of silica-gold nanoshells in a controlled setting.
• Significance lies in the potential for improved cancer treatment strategies, requiring further clinical validation.